Genitourinary malignancies and rheumatoid arthritis

Zeitschrift für Rheumatologie
M BoegemannS Zastrow

Abstract

Genitourinary neoplasms are relatively common and the frequency increases with age. Due to demographic changes more patients with inflammatory rheumatic diseases will have concomitant genitourinary tumors or they will develop them under antirheumatic therapy. In such cases, disease-modifying antirheumatic drugs (DMARD) and immunosuppressive therapy have to be carefully balanced on an individual basis. Based on the limited evidence available large increases in the risks from conventional and/or biological DMARDs for patients with genitourinary malignancies appear to be unlikely for most situations. In addition to these more common situations paraneoplastic symptoms in the musculoskeletal system can occur due to genitourinary malignancies. Moreover, novel drugs with immunostimulating activity for some genitourinary tumors may provoke autoimmune symptoms and thus present new challenges for interdisciplinary cooperation between rheumatologists and uro-oncologists. In this review, the diagnostic procedures, therapies and follow-up of cancers in the field of urology are delineated according to the current German and European guidelines. We describe the core issues that both urologists and rheumatologists should bear in mind. Direct c...Continue Reading

References

Dec 15, 1991·Annals of Internal Medicine·R S GastonJ J Curtis
May 11, 1999·JAMA : the Journal of the American Medical Association·C R PoundP C Walsh
Oct 9, 2003·The Journal of Urology·Hyung L KimRobert A Figlin
Apr 10, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Pierre I KarakiewiczJean-Jacques Patard
Feb 19, 2008·Current Opinion in Rheumatology·Jochanan E Naschitz, Itzhak Rosner
Mar 20, 2009·The New England Journal of Medicine·Gerald L AndrioleUNKNOWN PLCO Project Team
Mar 20, 2009·The New England Journal of Medicine·Fritz H SchröderUNKNOWN ERSPC Investigators
Jul 31, 2009·Urologia Internationalis·Emilio SaccoPierfrancesco Bassi
Nov 18, 2011·Rheumatology International·Jinane HakkouNajia Hajjaj-Hassouni
Dec 14, 2011·British Journal of Cancer·D M Parkin
Jun 5, 2012·The New England Journal of Medicine·Suzanne L TopalianMario Sznol
Jul 6, 2013·European Urology·Marko BabjukUNKNOWN European Association of Urology
Feb 22, 2014·Journal of Endourology·M Pilar LagunaUNKNOWN Clinical Research Office of the Endourological Society Renal Mass Study
May 14, 2014·Advances in Experimental Medicine and Biology·Georgios Gakis
Jul 23, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Robert J MotzerJennifer J Knox
Sep 16, 2014·International Journal of Cancer. Journal International Du Cancer·Jacques FerlayFreddie Bray
Jan 27, 2015·European Urology·Borje LjungbergAxel Bex
Apr 22, 2015·The Journal of Urology·Neel H PatelEric C Kauffman
May 13, 2015·Seminars in Oncology·Sergio BracardaRiccardo Danielli
Aug 25, 2015·European Urology·Peter AlbersUNKNOWN European Association of Urology

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

Related Papers

Journal of Research in Medical Sciences : the Official Journal of Isfahan University of Medical Sciences
Mansour SalesiZiba Farajzadegan
Expert Opinion on Biological Therapy
Tamas KonczLaszlo Gulacsi
© 2022 Meta ULC. All rights reserved